This is a list of selected publications.
A complete publication list can be found here

Glioma research
  1. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Hoogstrate Y, Draaisma K, Ghisai SA, van Hijfte L, Barin N, de Heer I, Coppieters W, van den Bosch TPP, Bolleboom A, Gao Z, Vincent AJPE, Karim L, Deckers M, Taphoorn MJB, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Lukacova S, Lombardi G, Leenstra S, Hanse M, Fleischeuer REM, Watts C, Angelopoulos N, Gorlia T, Golfinopoulos V, Bours V, van den Bent MJ, Robe PA, French PJ. Cancer Cell. 2023 Apr 10;41(4):678-692.e7. doi: 10.1016/j.ccell.2023.02.019.
  2. Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial. Draaisma K, Tesileanu CMS, de Heer I, Klein M, Smits M, Reijneveld JC, Clement PM, de Vos FYF, Wick A, Mulholland PJ, Taphoorn MJB, Weller M, Chinot OL, Kros JM, Verschuere T, Coens C, Golfinopoulos V, Gorlia T, Idbaih A, Robe PA, van den Bent MJ, French PJ. Clin Cancer Res. 2022 Jun 1;28(11):2440-2448. doi: 10.1158/1078-0432.CCR-21-3725.
  3. non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations. C Mircea S Tesileanu, Wies R Vallentgoed, Marc Sanson, Walter Taal, Paul M Clement, Wolfgang Wick, Alba Ariela Brandes, Jean Francais Baurain, Olivier L Chinot, Helen Wheeler, Sanjeev Gill, Matthew Griffin, Leland Rogers, Roberta Rudà, Michael Weller, Catherine McBain, Jaap Reijneveld, Roelien H Enting, Francesca Caparrotti, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Elisabeth Lim, Filip de Vos, Paul J Mulholland, Martin J B Taphoorn, Iris de Heer, Youri Hoogstrate, Maurice de Wit, Lorenzo Boggiani, Sanne Venneker, Jan Oosting, Judith VMG Bovée, Sara Erridge, Michael A Vogelbaum, Anna K Nowak, Warren P Mason, Johan M Kros, Pieter Wesseling, Ken Aldape, Robert B Jenkins, Hendrikus J Dubbink, Brigitta Baumert,, Vassilis Golfinopoulos, Thierry Gorlia, Martin van den Bent and Pim J French. Acta Neuropath. (2021) Mar 19. doi: 10.1007/s00401-021-02291-6
  4. Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study. Draaisma K, Chatzipli A, Taphoorn M, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Lukacova S, Lombardi G, Leenstra S, Hanse M, Fleischeuer R, Watts C, McAbee J, Angelopoulos N, Gorlia T, Golfinopoulos V, Kros JM, Verhaak RGW, Bours V, van den Bent MJ, McDermott U, Robe PA, French PJ.  J Clin Oncol. 2019 Nov 19:JCO1900367. doi: 10.1200/JCO.19.00367. 
  5. Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. Erdem-Eraslan L, Gravendeel LA, de Rooi J, Eilers PHC, Idbaih A, Spliet WGM, den Dunnen WFA, Teepen JL, Wesseling P, Sillevis Smitt PAE, Kros JM, Gorlia T, van den Bent MJ, French PJ.  J. Clin Oncol, (2013) 31:328-36 [IF 2011: 18.4]
  6. IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo. Bralten LBC, Kloosterhof NK, Balvers R, Sacchetti A, Lapre L, Lamfers M, Leenstra S, de Jonge HR, Kros JM, Jansen EEW, Struys EA, Jakobs C, Salomons GS, Diks SH, Peppelenbosch M, Kremer A, Hoogenraad CC, Sillevis Smitt PAE, French PJ.  Ann Neurol. (2011); 69:455-63 
  7. Kloosterhof NK, Bralten LB, French PJ, van den Bent MJ. IDH1 mutations: a fundamentally new understanding of diffuse glioma? Lancet Oncol. (2010); 12-83-91[IF in 2010: 17.8]
  8. Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB, Kloosterhof NK, De Moor B, Eilers PH, van der Spek PJ, Kros JM, Sillevis Smitt PA, van den Bent MJ, French PJ. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. (2009); 69:9065-72. Epub 2009 Nov 17. [IF in 2009: 7.5] link
Neuronal plasticity
  1. O'Connor V, Genin A, Davis S, Karishma KK, Doyere V, De Zeeuw CI, Sanger G, Hunt SP, Richter-Levin G, Mallet J, Laroche S, Bliss TV, French PJ. Differential amplification of intron-containing transcripts reveals long term potentiation-associated up-regulation of specific Pde10A phosphodiesterase splice variants. J. Biol. Chem. (2004): 279 (16):15841-9. [IF in 2004: 6.4] pdf
  2. Jones MW, Errington ML, French PJ, Fine A, Bliss TV, Garel S, Charnay P, Bozon B, Laroche S, Davis S. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci (2001);4(3):289-96. [IF in 2001: 15.7] link
Cystic Fibrosis
  1. French PJ, van Doorninck JH, Peters RH, Verbeek E, Ameen NA, Marino CR, de Jonge HR, Bijman J, Scholte BJ. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperaturesensitive processing defect in vivo. J. Clin. Invest. 1996;98(6):1304-12. [IF in 1997: 9.7] pdf
  2. van Doorninck JH, French PJ, Verbeek E, Peters RH, Morreau H, Bijman J, Scholte BJ. A mouse model for the cystic fibrosis delta F508 mutation. EMBO J. (1995) 14, 4403-4411 [IF in 1998: 13.2] pdf
  3. French PJ, Bijman J, Edixhoven M, Vaandrager AB, Scholte BJ, Lohmann SM, Nairn AC, de Jonge HR. Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channels by cGMPdependent protein kinase II. J. Biol. Chem. 270 (1995), 26626-26631 [IF in 1998: 7.2] pdf
All publications
 
Home